1. Oppenheimer J, Schwartz H, Mariash C, et al: Advances in our understanding of TH action at the cellular level. Endocr Rev 8:288 308, 1987.
2. Yen PM: Physiological and molecular basis of TH action. Physiol Rev 81:1097-1142, 2001.
3. Zulewski H, Muller B, Exer PM, et al: Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 82:771-776, 1997.
4. Refetoff S, Weiss RE, Usala SJ: The syndromes of resistance to TH. Endocr Rev 14:348-399, 1993.
5. Al-Adsani H, Hoffer LJ, Silva JE: Resting energy expenditure is sensitive to small dose changes in patients on chornic TH replacement. J Clin Endocrinol Metab 82:1118-1125, 1997.
6. Magnus-Levey A: Ueber den respiratorischen gaswechsel unter dem einfluss der thyroidea sowie unter verschiedenen pathologische zustand. Berl Klin Wschr 32:650, 1895.
7. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions.Endocr Rev. 2010 31:139-70.
8. Tata JR, Widnell CC: Ribonucleic acid synthesis during the early action of TH. Biochem J 98:604-620, 1966.
9. Schadlow AR, Surks MI, Schwartz HL, et al: Specific triiodothyronine binding sites in the anterior pituitary of the rat. Science 176:1252-1254, 1972.
10. Samuels HH, Tsai JS, Casanova J, et al: TH action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells. J Clin Invest 54:853-865, 1974.
11. Koerner D, Schwartz HL, Surks MI, et al: Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity. J Biol Chem 250:6417-6423, 1975.
12. Samuels HH, Stanley F, Casanova J: Relationship of receptor affinity to the modulation of TH nuclear receptor levels and growth hormone synthesis by L- triiodothyronine and iodothyronine analogues in cultured GH1 cells. J Clin Invest 63:1229-1240, 1979.
13. Schwartz HL, Trence D, Oppenheimer JH, et al: Distribution and metabolism of L- and D-triiodothyronine (T3) in the rat: preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biologic potency of T3 enantiomers. Endocrinology 113:1236-1243, 1983.
14. Sap J, Munoz A, Damm K, et al: The c-erb-A protein is a high-affinity receptor for TH. Nature 324:635-640, 1986.
15. Weinberger C, Thompson CC, Ong ES, et al: The c-erb-A gene encodes a TH receptor. Nature 324:641-646, 1986.
16. Harvey CB, Williams GR: Mechanism of TH action. Thyroid 12:441-6, 2002.
17. Forrest D Vennstrom B: Functions of TH receptors in mice. Thyroid 10: 41-52, 2000.
18. Flamant F, Samarut J. TH receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab. 2003 14:85-90.
19. Berry MJ, Larsen PR: The role of selenium in TH action. Endocr Rev 13:207-219, 1992.
20. Kohrle J: TH deiodinases--a selenoenzyme family acting as gate keepers to TH action. Acta Med Austriaca 23:17-30, 1996.
21. Silva JE, Dick TE, Larsen PR: The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology 103:1196-1207, 1978.
22. Larsen PR, Frumess RD: Comparison of the biological effects of thyroxine and triiodothyronine in the rat. Endocrinology 100:980-988, 1977.
23. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR Type iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-33
23a.van der Deure WM, Peeters RP, Visser TJMolecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol.2010 44(1):1-11, 2010.24. Jansen J, Friesema EC, Milici C, Visser TJ Thyroid hormone transporters in health and disease. Thyroid 15:757-68, 2005
25. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74:168-75, 2004
26. Spindler SR, MacLeod KM, Ring J, et al: TH receptors: binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem 250:4113-4119, 1975.
27. Rastinejad F, Perlmann T, Evans RM, et al: Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203-211, 1995
28. Perlman AJ, Stanley F, Samuels HH: TH nuclear receptor: evidence for multimeric organization in chromatin. J Biol Chem 257:930-938, 1982.
29. MacLeod KM, Baxter JD: Chromatin receptors for THs: interactions of the solubilized proteins with DNA. J Biol Chem 251:7380-7387, 1976.
30. Jump DB, Seelig S, Schwartz HL, et al: Association of TH receptor with rat liver chromatin. Biochemistry 20:6781-6789, 1981.
31. McKenna, N.J., R.B. Lanz, and B.W. O'Malley: Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 20:321-344. 199932. Zhang J, Lazar MA: The mechanism of action of THs. Annu Rev Physiol. 62:439-466, 2000.
33. Thompson CC, Weinberger C, Lebo R, et al: Identification of a novel TH receptor expressed in the mammalian central nervous system. Science 237:1610-1614, 1987.
34. Drabkin H, Kao FT, Hartz J, et al: Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A 85:9258-9262, 1988..
35. Mader S, Kumar V, de VH, et al: Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 338:271-274, 1989.
36. Umesono K, Evans RM: Determinants of target gene specificity for steroid/TH receptors. Cell 57:1139-1146, 1989.
37. Yen PM, Ikeda M, Wilcox EC, et al. 1994 Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity. J Biol Chem 269:12704-12709
38. Nelson CC, Faris JS, Hendy SC, et al: Functional analysis of the amino acids in the DNA recognition alpha- helix of the human TH receptor. Mol Endocrinol 7:1185-1195, 1993.
39. Wagner RL, Apriletti JW, McGrath ME, et al: A structural role for hormone in the TH receptor. Nature 378:690-697, 1995.
40. Hu X, Lazar MA: The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93-6, 1999.
41. Nagy L, Kao HY, Love JD, et al: Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 13: 3209-16, 1999.
42. Perissi, V., L. M. Staszewski, E. M. McInerney, et al: Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13: 3198-208, 1999.
43. Feng, W., R. C. Ribeiro, R. L. Wagner, et al: Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280: 1747-9, 1998.
44. Lazar MA, Hodin RA, Darling DS, et al: Identification of a rat c-erbAa-related protein which binds deoxyribonucleic acid but does not bind TH. Mol Endocrinol 2:893-901, 1988.
45. Mitsuhashi T, Tennyson GE, Nikodem VM: Alternative splicing generates messages encoding rat c-erbA proteins that do not bind TH. Proc Natl Acad Sci U S A 85:5804-5808, 1988.
46. Izumo S, Mahdavi V: TH receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334:539-542, 1988.
47. Nakai A, Seino S, Sakurai A, et al: Characterization of a TH receptor expressed in human kidney and other tissues. Proc Natl Acad Sci U S A 85:2781-2785, 1988.
48. Schueler PA, Schwartz HL, Strait KA, et al: Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the a and ß forms for the acetic acid analog and failure of the human testis and kidney products to bind T3. Mol Endocrinol 4:227-234, 1990.
49. Lazar MA, Hodin RA, Chin WW: Human carboxy-terminal variant of a-type c-erbA inhibits trans-activation by TH receptors without binding TH. Proc Natl Acad Sci U S A 86:7771-7774, 1989.
50. Koenig RJ, Lazar MA, Hodin RA, et al: Inhibition of TH action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337:659-661, 1989.
51. Rentoumis A, Chatterjee VKK, Madison LD, et al: Negative and positive transcriptional regulation by TH receptor isoforms. Mol Endocrinol 4:1522-1531, 1990.
52. Katz D, Berrodin TJ, Lazar MA: The unique C-termini of the TH receptor variant, c-erbAa2, and TH receptor a1 mediate different DNA-binding and heterodimerization properties. Mol Endocrinol 6:805-814, 1992.
53. Nagaya T, Jameson JL: Distinct dimerization domains provide antagonist pathways for TH receptor action. J Biol Chem 268:24278-24282, 1993.
54. Yang YZ, Burgos-Trinidad M, Wu Y, et al: TH receptor variant alpha2. Role of the ninth heptad in dna binding, heterodimerization with retinoid X receptors, and dominant negative activity. J Biol Chem 271:28235-28242, 1996.
55. Tagami T, Kopp P, Johnson W, et al: The TH receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors. Endocrinology 139:2535-2544, 1998..
56. Hodin RA, Lazar MA, Chin WW: Differential and tissue-specific regulation of the multiple rat c- erbA messenger RNA species by TH. J Clin Invest 85:101-105, 1990.
57. Katz D, Lazar MA: Dominant negative activity of an endogenous TH receptor variant (alpha 2) is due to competition for binding sites on target genes. J Biol Chem 268:20904-20910, 1993..
58. Farsetti A, Lazar J, Phyillaier M, et al: Active repression by TH receptor splicing variant alpha2 requires specific regulatory elements in the context of native triiodothyronine-regulated gene promoters. Endocrinology 138:4705-4712, 1997.
59. Liu RT, Suzuki S, Miyamoto T, et al: The dominant negative effect of TH receptor splicing variant alpha 2 does not require binding to a thyroid response element. Mol Endocrinol 9:86-95, 1995.
60. Katz D, Reginato M, Lazar M: Functional regulation of TH receptor variant TR alpha 2 by phosphorylation. Mol Cell Biol 15:2341 2348, 1995.
61. Miyajima N, Horiuchi R, Shibuya Y, et al: Two erbA homologs encoding proteins with different T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell 57:31-39, 1989.
62. Lazar MA, Hodin RA, Darling DS, et al: A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA alpha transcriptional unit. Mol Cell Biol 9:1128-1136, 1989.
63. Spanjaard RA, Nguyen VP, Chin WW: Rat Rev-erbA alpha, an orphan receptor related to TH receptor, binds to specific TH response elements. Molecular Endocrinology 8: 286-295, 1994.
64. Harding HP, Lazar MA: The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol 15:4791-4802, 1995.
65. Zamir I, Dawson J, Lavinsky RM, et al: Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci U S A 94:14400-14405, 1997.
66. Munroe SH, Lazar MA: Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA. J Biol Chem 266:22083-22086, 1991.
67. Lazar MA, Hodin RA, Cardona G, et al: Gene expression from the c-erbA alpha/Rev-ErbA alpha genomic locus. Potential regulation of alternative splicing by opposite strand transcription. J Biol Chem 265:12859-12863, 1990.
68. Hodin RA, Lazar MA, Wintman BI, et al: Identification of a TH receptor that is pituitary- specific. Science 244:76-79, 1989.
69. Oberste-Berghaus CK, Zanger K, Hashimoto K, et al: TH-independent interaction between the TH receptor beta2 amino terminus and coactivators. J Biol Chem 275: 1787-92, 2000.
70. Tomura H, Lazar J, Phyillaier M, et al: The N-terminal region (A/B) of rat TH receptors alpha 1, beta 1, but not beta 2 contains a strong TH-dependent transactivation function. Proc Natl Acad Sci U S A 92:5600-5604, 1995.
71. Satoh T, Yamada M, Iwasaki T, et al: Negative regulation of the gene for the preprothyrotropin-releasing hormone from the mouse by TH requires additional factors in conjunction with TH receptors. J Biol Chem 271:27919-27926, 1996.
72. Safer JD, Langlois MF, Cohen R, et al: Isoform variable action among TH receptor mutants provides insight into pituitary resistance to TH. Mol Endocrinol 11:16-26, 1997.
73. Chassande, O., A. Fraichard, K. Gauthier, et al: Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 11: 1278-90, 1997.
74. Williams GR. Cloning and characterization of two novel TH receptor beta isoforms. Mol Cell Biol. 20:8329-42, 2000.
75. Strait KA, Schwartz HL, Perez-Castillo A, et al: Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem 265:10514-10521, 1990.
76. Forrest D, Sjoberg M, Vennstrom B: Contrasting developmental and tissue-specific expression of alpha and beta TH receptor genes. EMBO J 9:1519-1528, 1990.
77. Cook CB, Kakucska I, Lechan RM, et al: Expression of TH receptor ß2 in rat hypothalamus. Endocrinology 130:1077-1079, 1992.
78. Lechan RM, Qi Y, Berrodin TJ, et al: Immunocytochemical delineation of TH receptor beta 2-like immunoreactivity in the rat central nervous system. Endocrinology 132:2461-2469, 1993.
79. Bradley DJ, Towle HC, Young WS, 3rd: Alpha and beta TH receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo. Proc Natl Acad Sci U S A 91:439-443, 1994.
80. Oppenheimer JH, Schwartz HL: Molecular basis of TH-dependent brain development 18:462-475, 1997.
81. Kanamori A, Brown DD: The regulation of TH receptor beta genes by TH in Xenopus laevis. J Biol Chem 267:739-745, 1992.
82. Yen PM, Feng X, Flamant F,et al: Effects of Hormonal Status and TH Receptor (TR) Isoforms on Hepatic Gene Expression Profiles in TR Knockout Mice. EMBO reports 4:581-587, 2003.
83. Feng X, Yuan J, Meltzer PB, Yen PM. TH regulation of hepatic genes in vivo detected by cDNA microarray. Mol Endocrinol 2000; 14: 947-955.
84. Flores-Morales A, Gullberg H, Fernandez L, et al: Patterns of liver gene expression governed by TRbeta.Mol Endocrinol. 16:1257-68, 2002.
84a. Leedman PJ, Stein AR, Chin WW Regulated specific protein binding to a conserved region of the 3'-untranslated region of thyrotropin beta-subunit mRNA. Mol Endocrinol 9:375-87, 1995.
84b. Van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res. 103:919-28, 2008.
85. Williams GR, Brent GA. TH response elements. In B. D. Weintraub: Molecular Endocrinology: Basic Concepts and Clinical Correlations. New York, Raven Press, 1994.
86. Katz RW, Subauste JS, Koenig RJ: The interplay of half-site sequence and spacing on the activity of direct repeat TH response elements. J Biol Chem 270:5238-5242, 1995.
87. Katz RW, Koenig RJ: Nonbiased identification of DNA sequences that bind TH receptor alpha 1 with high affinity. J Biol Chem 268:19392-19397, 1993.
88. Umesono K, Murakami KK, Thompson CC, et al: Direct repeats as selective response elements for the TH, retinoic acid, and vitamin D receptors. Cell 65:1255-1266, 1991.
89. Näär A, Boutin J, SM L, et al: The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267-1279, 1991.
90. Mangelsdorf D, Evans R: The RXR heterodimers and orphan receptors. Cell 83:841-850, 1995.
91. Wahlstrom GM, Sjoberg M, Andersson M, et al: Binding characteristics of the TH receptor homo- and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol 6:1013-1022, 1992.
92. Yen PM, Brubaker JH, Apriletti JW, Baxter JD, Chin WW 1994 Roles of T3 and DNA-binding on thyroid hormone receptor complex formation. Endocrinology 134:1075-1081
93. Perlmann T, Rangarajan PN, Umesono K, et al: Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411-1422, 1993.
94. Zechel C, Shen XQ, Chen JY, et al: The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. Embo J 13:1425-1433, 1994.
95. Collingwood TN, Butler A, Tone Y, et al: TH-mediated enhancement of heterodimer formation between TH receptor beta and retinoid X receptor. J Biol Chem 272:13060-13065, 1997.
96. Yen PM, Darling DS, Carter RL, et al: Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem 267:3565-3568, 1992.
97. Levin AA, Sturzenbecker LJ, Kazmer S, et al: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa. Nature 355:359-361, 1992.
98. Heyman RA, Mangelsdorf DJ, Dyck JA, et al: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406, 1992.
99. Zhang J, Lazar MA: The mechanism of action of THs. Annu Rev Physiol 62, 439-466, 2000.
99a. Araki O, Ying H, Furuya F, Zhu X, Cheng SY 2005 Thyroid hormone receptor b mutants: dominant negative regulators of peroxisome proliferator-activated receptor g action. Proc Natl Acad Sci USA 102:16251–16256
99b. HansenMK,ConnollyTM 2008 Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr Opin Investig Drugs 9:247–255
99c. Hart CM 2008 The role of PPAR in pulmonary vascular disease. J Investig Med 56:518–521
99d. Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE 2006 Crosstalk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem 281:295–302
100. Torchia J, Glass C, Rosenfeld MG: Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol. 10:373-383, 1998
101. Brent GA, Dunn MK, Harney JW, et al: TH aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. New Biol 1:329-336, 1989.
102. Damm K, Thompson CC, Evans RM: Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-597, 1989.
103. Baniahmad A, Kohne AC, Renkawitz R: A transferable silencing domain is present in the TH receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11:1015-1023, 1992.
104. Chen JD, Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457, 1995.
105. Horlein AJ, Naar AM, Heinzel T, et al: Ligand-independent repression by the TH receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404, 1995.
106. Nan X, Ng H, Johnson CA et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-9, 1998.
107. Wade PA, Gegonne A, Jones PL, et al: Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23: 62-6, 1999.
108. Gothe S, Wang Z, Ng L, et al: Mice devoid of all known TH receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13: 1329-41, 1999.
109. Gauthier K, Chassande O, Plateroti M, et al: Different functions for the TH receptors TRalpha and TRbeta in the control of TH production and post-natal development. Embo J 18: 623-31, 1999.
110. Onate SA, Tsai SY, Tsai MJ, et al: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357, 1995.
111. Voegel JJ, Heine MJS, Zechel C, et al: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675, 1996.
112. Hong H, Kohli K, Trivedi A, et al: GRIP1, a novel mouse protein that serves as a transcrptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952, 1996.
113. Yang X-J, Ogryzko VV, Nishikawa J, et al: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 319-324, 1996.
114. Kwok RP, Lundblad JR, Chrivia JC, et al: Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226, 1994.
115. Eckner R, Ewen ME, Newsome D, et al: Molecular cloning and functional analysis of the adenovirus E1A- associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8:869-884, 1994.
116. Torchia J, Rose DW, Inostrova J, et al: The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function.Nature 387:677-684, 1997.
117. Fondell JD, Guermah M, Malik S, et al: TH receptor-associated proteins and general positive cofactors mediate TH receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc Natl Acad Sci U S A 96:1959-1964, 1999.
118. Rachez C, Suldan Z, Ward J, et al: A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell- free system. Genes Dev 12:1787-1800, 1998.
119. Ito M, Roeder RG: The TRAP/SMCC/Mediator complex and TH receptor function. Trends Endocrinol Metab. 12:127-134, 2001.
120. Rachez C, Freedman, LP: Mediator complexes and transcription. Curr Opin Cell Biol. 13:274-280, 2001.
121. Sharma D, Fondell JD: Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to TH-responsive promoters in vivo. Proc Natl Acad Sci U S A. 99:7934-7939, 2002.
122. Shang Y, Hu X, DiRenzo J, et al: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:843-852, 2000.
123. Reid G, Hubner MR, Metivier R,et al: Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695-707, 2003.
124. Liu Y, Xia X, Fondell JD, Yen PM 2006 Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol Endocrinol 20:483-90
125. DiRenzo J, Shang Y, Phelan M, et al. 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541-9.
126. Nagaich AK, Walker DA, Wolford R, Hager GL 2004 Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14:163-74
127. Hollenberg AN, Monden T, Flynn TR, et al: The human thyrotropin-releasing hormone gene is regulated by TH through two distinct classes of negative TH response elements. Mol Endocrinol 9:540-550, 1995.
128. Chatterjee VKK, Lee JK, Rentoumis A, et al: Negative regulation of the thyroid-stimulating hormone alpha gene by TH: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci U S A 86:9114-9118, 1989.
129. Bodenner DL, Mroczynski MA, Weintraub BD, et al: A detailed functional and structural analysis of a major TH inhibitory element in the human thyrotropin beta-subunit gene. J Biol Chem 266:21666-21673, 1991.
130. Zhang XK, Wills KN, Husmann M, et al: Novel pathway for TH receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 11:6016-6025, 1991.
131. Lopez G, Schaufele F, Webb P, et al: Positive and negative modulation of Jun action by TH receptor at a unique AP1 site. Mol Cell Biol. 1993 13:3042-9.
132. Pernasetti F, Caccavelli L, Van de Weerdt C, et al: TH inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Mol Endocrinol 11:986-996, 1997.
133. Tansey WP, Catanzaro DF: Sp1 and TH receptor differentially activate expression of human growth hormone and chorionic somatomammotropin genes. J Biol Chem 266:9805-9813, 1991.
134. Schaufele F, West BL, Reudelhuber TL: Overlapping Pit-1 and Sp1 binding sites are both essential to full rat growth hormone gene promoter activity despite mutually exclusive Pit-1 and Sp1 binding. J Biol Chem 265:17189-17196, 1990.
135. Schaufele F, West BL, Baxter JD: Synergistic activation of the rat growth hormone promoter by Pit-1 and the TH receptor. Mol Endocrinol 6:656-665, 1992.
136. Barrera-Hernandez G, Zhan Q, Wong R, et al: TH receptor is a negative regulator in p53-mediated signaling pathways. DNA Cell Biol 17:743-750, 1998.
137. Qi JS, Yuan Y, Desai-Yajnik V, et al: Regulation of the mdm2 oncogene by TH receptor. Mol Cell Biol 19:864-872, 1999.
138. Lutz M, Burke LJ, LeFevre P, et al: TH-regulated enhancer bloc
king: cooperation of CTCF and TH receptor The EMBO Journal 22: 1579-1587, 2003.
138a. Matsushita A, Sasaki S, Kashiwabara Y, Nagayama K, Ohba K, Iwaki H, Misawa H, Ishizuka K, Nakamura H. Essential role of GATA2 in the negative regulation of thyrotropin beta gene by thyroid hormone and its receptors. Mol Endocrinol. 2007 21(4):865-84.
138b. Wang D, Xia X, Liu Y, Oetting A, Walker RL, Zhu Y, Meltzer P, Cole PA, Shi YB, Yen PM. Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol. 2009 23:600-9.
139. Tagami T, Madison LD, Nagaya T, et al: Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by TH. Mol Cell Biol 17:2642-2648, 1997.
140. Tagami T, Gu WX, Peairs PT, et al: A novel natural mutation in the TH receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol 12:1888-1902, 1998.
141. Weiss RE, Xu J, Ning G, Pohlenz J, O'Malley BW, Refetoff S 1999 Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. Embo J 18:1900-4.
142. Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, et al. 2005 Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest 115:2517-23.
142a. Wang D, Xia X, Weiss RE, Refetoff S, Yen PM.Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHalpha promoter.PLoS One.2010 5:e9853.
142b. Umezawa R, Yamada M, Horiguchi K, Ishii S, Hashimoto K, Okada S, Satoh T, Mori M. Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor. Endocrinology. 2009;150:3425-32.
142c. Visser WE, Heemstra KA, Swagemakers SM, Ozgür Z, Corssmit EP, Burggraaf J, van Ijcken WF, van der Spek PJ, Smit JW, Visser TJ. Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. J Clin Endocrinol Metab. 2009 Sep;94(9):3487-96
143. Sasaki S, Lesoon-Wood LA, Dey A, et al: Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. Embo J 18: 5389-98, 1999.
143a. Park SW, HuangW-H, Persaud SD, WeiLNRIP140in thyroid hormone-repression and chromatin remodeling of Crabp1 gene during adipocyte differentiation. Nucleic Acids Research, 2009, Vol. 37, No. 21 7085-7094
143b. Kurokawa R, Rosenfeld MG, Glass CK. Transcriptional regulation through noncoding RNAs and epigenetic modifications. RNA Biol. 2009 Jul;6(3):233-6.
143c. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest. 2009 Sep;119(9):2772-86
143d. Aranda A, Martínez-Iglesias O, Ruiz-Llorente L, García-Carpizo V, Zambrano A. Thyroid receptor: roles in cancer. Trends Endocrinol Metab. 2009 Sep;20(7):318-24. Epub 2009 Aug 26.
143e. Bonamy, G.M. and Allison, L.A. (2006) Oncogenic conversion of thyroid hormone receptor by altered nuclear transport. Nucl. Recept. Signal. 4, e008
143f. Gonzalez-Sancho, J.M. et al. (2003) Thyroid hormone receptors/THR genes in human cancer. Cancer Lett. 192, 121–132
143g. Conde, I. et al. (2006) Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann. Oncol. 17, 60–64
143h. Horkko, T.T. et al. (2006) Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int. J. Cancer 118, 1653–1659
143i. Chan, I.H. and Privalsky, M.L. (2006) Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25, 3576–3588
143j. Chen, R.N. et al. (2008) Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Res. 68, 1697–1706
143k. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY 2008 Regulation of β-catenin by a novel nongenomic action of thyroid hormone βreceptor. Mol Cell Biol 28:4598 –4608
143l. Furuya, F. et al. (2006) Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc. Natl. Acad. Sci. U. S. A. 103, 1780–1785
144. Abel ED, Boers ME, Pazos-Moura, C, et al: Divergent roles for TH receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest 104, 291-300, 1999.
145. Wikstrom L, Johansson C, Salto C, et al: Abnormal heart rate and body temperature in mice lacking TH receptor alpha 1. Embo J 17, 455-461, 1998.
146. Fraichard A, Chassande O, Plateroti, M et al: The T3R alpha gene encoding a TH receptor is essential for post-natal development and TH production. Embo J 16, 4412-4420, 1997.
148. Johansson C, Vennstrom B, Thoren P: Evidence that decreased heart rate in TH receptor-alpha1- deficient mice is an intrinsic defect. Am J Physiol 275:R640-646, 1998.
149.Macchia, P.E., Takeuchi, Y., Kawai, T., Cua, K., Gauthier, K., Chassande, O., Seo, H., Hayashi, Y., Samarut, J., Murata, Y., Weiss, R.E. and Refetoff, S. (2001) Increased sensitivity to TH in mice with complete deficiency of TH receptor alpha. Proc Natl Acad Sci U S A 98, 349-354.
150. Forrest D, Hanebuth E, Smeyne RJ, et al: Recessive resistance to TH in mice lacking TH receptor beta: evidence for tissue-specific modulation of receptor function. Embo J 15:3006-3015, 1996.
151. Weiss RE, Forrest D, Pohlenz J, et al: Thyrotropin regulation by TH in TH receptor beta-deficient mice. Endocrinology 138:3624-3629, 1997.
152. Refetoff S, DeWind LT, DeGroot LJ: Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to TH. J Clin Endocrinol Metab 27:279-294, 1967.
153. Ng L, Hurley JB, Dierks, B, et al: A TH receptor that is required for the development of green cone photoreceptors. Nat Genet 27, 94-98, 2001.
154. Kaneshige M, Kaneshige K, Zhu X, et al: Mice with a targeted mutation in the TH beta receptor gene exhibit impaired growth and resistance to TH. Proc Natl Acad Sci U S A 97, 13209-13214, 2000.
155. Hashimoto K, Curty FH, Borges PP, et al: An unliganded TH receptor causes severe neurological dysfunction. Proc Natl Acad Sci U S A 98, 3998-4003, 2001.
156. Shibusawa N, Hashimoto K, Nikrodhanond AA, et al: TH action in the absence of TH receptor DNA-binding in vivo. J Clin Invest. 112: 497-9, 2003.
157. Baumann CT, Maruvada P, Hager GL, Yen PM 2001 Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-45
158. Bassett JH, Harvey CB, Williams GR 2003 Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213:1-11
159. Cheng SY, Gong QH, Parkison C, et al. 1987 The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum. Journal of Biological Chemistry 262:11221-11227
160. Kato H, Fukuda T, Parkison C, McPhie P, Cheng SY 1990 Cytoplasmic thyroid hormone-binding protein is a monomer of pyruvate kinase. Proceedings of the National Academy of Science 86:7681-7685
161. Sterling K, Brenner MA 1995 Thyroid hormone action: effect of triiodothyronine on mitochondrial adenine nucleotide translocase in vivo and in vitro. Metabolism 44:193-199
162. Wrutniak C, Cassar-Malek I, Marchal S, et al. 1995 A 43 kD protein related to c-erb A alpha 1 is located in the mitochondrial matrix of rat liver. Journal of Biological Chemistry 270:16347-16354
163. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H 2005 Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19:102-12
164. Moeller LC, Dumitrescu AM, Refetoff S 2005 Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol Endocrinol 19:2955-63
165. Bergh JJ, Lin HY, Lansing L, et al. 2005 Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-71
166. Farwell AP, Tranter MP, Leonard JL 1995 Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes. Endocrinology 136:3909-15
167. Davis PJ, Davis FB, Cody V 2005 Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 16:429-35
167a. Asai S, Cao X, Yamauchi M, Funahashi K, Ishiguro N, Kambe F. Thyroid hormone non-genomically suppresses Src thereby stimulating osteocalcin expression in primary mouse calvarial osteoblasts. Biochem Biophys Res Commun. 2009 Sep 11;387(1):92-6. Epub 2009 Jun 27
167b. Guigon CJ, Cheng SY. Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol. 2009 Sep 24;308(1-2):63-9.
168. Underwood AH, Emmett JC, Ellis D, et al. 1986 A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. Nature 324:425-9
169. Morkin E, Ladenson P, Goldman S, Adamson C 2004 Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol 37:1137-46
170. Taylor AH, Stephan ZF, Steele RE, Wong NC 1997 Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol Pharmacol 52:542-7
171. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS 1998 A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5:299-306
172. Grover GJ, Mellstrom K, Ye L, et al. 2003 Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc Natl Acad Sci U S A 100:10067-72
173. Johansson L, Rudling M, Scanlan TS, et al. 2005 Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci U S A 102:10297-302
173a. Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL, Erion MD. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology. 2009 Feb;49(2):407-17.174.
174. Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B.Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med.2010 362:906-16.
175. Scanlan TS, Suchland KL, Hart ME, et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-42
176. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S 2002 Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-33176.
177. Cortez LM, Farías RN, Chehín RN. Protective effect of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraiodothyroacetic acids on serum albumin fibrillation. Eur Biophys J. 2009 Sep;38(7):857-63. Epub 2009 Apr 18.
178. Hercbergs A, Davis PJ, Davis FB, Ciesielski MJ, Leith JT. Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac). Cell Cycle. 2009 Aug 15;8(16):2586-91